|
Market Closed -
Toronto S.E.
12:38:16 16/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0150 CAD | 0.00% |
|
0.00% | -25.00% |
| 28/08 | Waverley Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 18/07 | Waverley Pharma Inc. Announces CFO Changes, Effective July 24, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6L | - | - | - | - | - |
| 7.02TCr | |||||
| 6.26TCr | |||||
| 2.74TCr | - | ||||
| 2.57TCr | |||||
| 2.48TCr | - |
- Stock Market
- Stocks
- WAVE Stock
- Charts Waverley Pharma Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
